Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC).

Matthew Raymond Smith, Michael Borre, Per Rathenborg, Patrick Werbrouck , Hendrik von Poppel , Axel Heidenreich, Peter Iversen, Edwina Baskin-Bey, Frank Perabo, De Phung, Bertrand Tombai

OriginalsprogEngelsk
TidsskriftJournal of Clinical Oncology
Vol/bind31
Udgave nummer15_suppl
Sider (fra-til)5001
Antal sider1
ISSN0732-183X
StatusUdgivet - 2013
BegivenhedAmerican Society of Clinical Oncology, Annual Meeting - Chicago , USA
Varighed: 31 maj 20134 jun. 2013

Konference

KonferenceAmerican Society of Clinical Oncology, Annual Meeting
Land/OmrådeUSA
ByChicago
Periode31/05/201304/06/2013

Citationsformater